Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 7NIH 4INDUSTRY 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Neoplasms 4Lung Neoplasms 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Rectal Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Unresectable Non-small Cell Lung Cancer 1Tobacco Use Cessation 1Recurrence 1Rectal Diseases 1Pancreatic Cancer Liver Metastases 1Ovarian Neoplasms 1Ototoxicity 1Neoplasms, Second Primary 1Neoplasms by Site 1Neoplasm Metastasis 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Intestinal Neoplasms 1Intestinal Diseases 1Hodgkin Disease 1Hearing Loss 1HER2 Positive Metastatic Breast Cancer 1Gastrointestinal Neoplasms 1Gastrointestinal Diseases 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2pembrolizumab 1lenvatinib 1fluzoparib 1apatinib 1Surgical Procedures, Operative 1Quality of Life 1Paclitaxel 1Nutritional Status 1Neoadjuvant Therapy 1Interviews as Topic 1Indocyanine Green 1Drug Therapy 1Diagnostic Imaging 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Carcinoma, Ovarian Epithelial × Drug Therapy × Clear all
NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Shanghai Gynecologic Oncology Group

Phase 1/2 Not yet recruiting
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡